Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL184 Simulated Rabies PEP Study
NCT01228383Phase 2Completed
- Sponsor
- Crucell
- Start
- Dec 2011
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CL184 in rabies, sponsored by Crucell. Started Dec 2011; status: completed.
02
Drugs
CL184
03
Conditions
rabies
Beyond the preview
Go deeper on NCT01228383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228383.